Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H8N2O2 |
| Molecular Weight | 152.1506 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C=C(C=CC1=O)C(N)=O
InChI
InChIKey=JLQSXXWTCJPCBC-UHFFFAOYSA-N
InChI=1S/C7H8N2O2/c1-9-4-5(7(8)11)2-3-6(9)10/h2-4H,1H3,(H2,8,11)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Excretion of tryptophan-niacin metabolites by young men: effects of tryptophan, leucine, and vitamin B6 intakes. | 1980 Oct |
|
| Identification of N1-methyl-2-pyridone-5-carboxamide and N1-methyl-4-pyridone-5-carboxamide as components in urine extracts of individuals consuming coffee. | 2002 Oct 15 |
|
| Conversion ratio of tryptophan to niacin in Japanese women fed a purified diet conforming to the Japanese Dietary Reference Intakes. | 2004 Dec |
|
| The effect of N-methyl-2-pyridone-5-carboxamide--A nicotinamide catabolite on poly ADP-rybosylation and oxidative stress injury in endothelial cells. | 2005 |
|
| Quantitation of the niacin metabolites 1-methylnicotinamide and l-methyl-2-pyridone-5-carboxamide in random spot urine samples, by ion-pairing reverse-phase HPLC with UV detection, and the implications for the use of spot urine samples in the assessment of niacin status. | 2005 Mar 25 |
|
| The novel nucleotide 4KNTP, in high concentrations in erythrocytes of renal failure children: a comparison with accumulation of other putative precursors in the plasma. | 2006 |
|
| Comparison of metabolic fates of nicotinamide, NAD+ and NADH administered orally and intraperitoneally; characterization of oral NADH. | 2006 Apr |
|
| Estimation of aldehyde oxidase activity in vivo from conversion ratio of N1-methylnicotinamide to pyridones, and intraspecies variation of the enzyme activity in rats. | 2006 Feb |
|
| Accumulation of poly(ADP-ribose) polymerase inhibitors in children with chronic renal failure. | 2006 Jun |
|
| Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. | 2010 May |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID70220374
Created by
admin on Sat Dec 16 08:58:57 GMT 2023 , Edited by admin on Sat Dec 16 08:58:57 GMT 2023
|
PRIMARY | |||
|
68139USC7W
Created by
admin on Sat Dec 16 08:58:57 GMT 2023 , Edited by admin on Sat Dec 16 08:58:57 GMT 2023
|
PRIMARY | |||
|
N1-Methyl-2-pyridone-5-carboxamide
Created by
admin on Sat Dec 16 08:58:57 GMT 2023 , Edited by admin on Sat Dec 16 08:58:57 GMT 2023
|
PRIMARY | |||
|
27410
Created by
admin on Sat Dec 16 08:58:57 GMT 2023 , Edited by admin on Sat Dec 16 08:58:57 GMT 2023
|
PRIMARY | |||
|
701-44-0
Created by
admin on Sat Dec 16 08:58:57 GMT 2023 , Edited by admin on Sat Dec 16 08:58:57 GMT 2023
|
PRIMARY | |||
|
69698
Created by
admin on Sat Dec 16 08:58:57 GMT 2023 , Edited by admin on Sat Dec 16 08:58:57 GMT 2023
|
PRIMARY |
PARENT (METABOLITE)
SUBSTANCE RECORD
